Atlas Trials

Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer Patients

Clinical trial NCT03489551 · COMPLETED

Trial details

NCT number
NCT03489551
Sponsor
Michelle Weckmann
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Stem Cell Transplant ComplicationsDelirium
Start date
2011-11-01
Primary completion
2013-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.